The revised guideline includes a simplified algorithm for inhaled therapy with the choice of second-line therapy determined by the presence of asthma or steroid responsiveness. There are also updated recommendations on prophylactic antibiotics, oxygen therapy, managing pulmonary hypertension and self-management plans.
In addition prescribers can turn to MIMS for a summary of NICE's new antimicrobial prescribing guidance for acute COPD exacerbations. NICE's recommendations on suitable agents and dosages have been added to the MIMS table of antibiotic treatment regimens - again available online and in the print issue of MIMS.
In the new guidance NICE urges healthcare professionals to take into account the risk of antimicrobial resistance when prescribing repeated courses of antibiotics for COPD exacerbations.